RxDoctor Payments Data

Dorothy Blanks

Nurse Practitioner · Philadelphia, PANPI 1356992325

Payments from drug & device makers

$6,317in general payments, 2019–2025

Across 175 payments — averaging $36.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$935
  • AbbVie$891
  • GSK$840
  • Johnson & Johnson$493
  • Biohaven Pharmaceutical Holding Company Ltd.$380
  • Gilead$361
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$6,317100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,317 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,464
JardianceEmpagliflozin15$12,266
Albuterol Sulfate HfaAlbuterol Sulfate57$1,331
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,237
Atorvastatin Calcium78$1,064
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic12$727
Nifedipine ErNifedipine12$451
Tamsulosin Hcl18$425
Amlodipine Besylate51$372
Diclofenac Sodium11$367
Metformin Hcl30$347
Gabapentin24$288
Lisinopril35$285
Omeprazole16$214
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$840$13,46417 claims
Boehringer IngelheimJardiance$117$12,26615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →